Virological and Immunological Status of the People Living with HIV/AIDS Undergoing ART Treatment in Nepal

Table 5

Immunological status of the patients under different ART regimens in Nepal. The table shows the number of patients treated with different ART regimens and having designated CD4⁺ T cell count groups. In the parentheses are the percentages out of total patients with the particular regimens.

ART regimen	Total cases	Number and percentage of patients with given CD4^+ T cell count (cells/cumm)
		<100	100–200	201–350	>350–500	>500	<350
AZT/3TC/NVP	163	4 (2.45%)	11 (6.75%)	41 (25.15%)	35 (21.74%)	72 (44.17%)	56 (34.36%)
TDF/3TC/NVP	238	7 (2.94%)	18 (7.56%)	54 (22.68%)	61 (25.63%)	98 (41.18%)	79 (33.2%)
TDF/3TC/EFV	335	13 (3.88%)	24 (7.16%)	87 (25.97%)	95 (28.36%)	116 (34.63%)	124 (37.02%)
AZT/3TC/EFV	34	0	2 (5.88%)	7 (20.59%)	9 (26.47%)	16 (47.06%)	9 (26.47%)
ABC/3TC/EFV	19	0	3 (15.79%)	4 (21.05%)	3 (15.79%)	9 (47.37%)	7 (36.84%)
Other	37	2 (5.41%)	3 (8.11%)	6 (16.22%)	9 (24.32%)	17 (45.95%)	11 (29.73%)
Total	826	26 (3.14%)	61 (7.38%)	199 (24.09%)	212 (26.67%)	256 (30.99%)	286 (34.62%)